| 000 | 01362 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511175816.0 | ||
| 264 | 0 | _c19920317 | |
| 008 | 199203s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00081a009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScopes, D I | |
| 245 | 0 | 0 |
_aNew kappa-receptor agonists based upon a 2-[(alkylamino)methyl]piperidine nucleus. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cFeb 1992 |
||
| 300 |
_a490-501 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnalgesics _xchemical synthesis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Opioid _xdrug effects |
| 650 | 0 | 4 | _aReceptors, Opioid, kappa |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aVas Deferens _xdrug effects |
| 700 | 1 | _aHayes, N F | |
| 700 | 1 | _aBays, D E | |
| 700 | 1 | _aBelton, D | |
| 700 | 1 | _aBrain, J | |
| 700 | 1 | _aBrown, D S | |
| 700 | 1 | _aJudd, D B | |
| 700 | 1 | _aMcElroy, A B | |
| 700 | 1 | _aMeerholz, C A | |
| 700 | 1 | _aNaylor, A | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 35 _gno. 3 _gp. 490-501 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00081a009 _zAvailable from publisher's website |
| 999 |
_c1317266 _d1317266 |
||